TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: nerve fiber layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Emotional well-being scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Limitations in social activities due to health
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement in IPSS storage symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in LUTS-related quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean RI (endothelial function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxidative stress biomarkers (NO, GSH, MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systemic inflammation biomarker (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neurohormonal response
Endpoint domain: Mortality/survival
Primary endpoint: NT-proBNP reduction ≥ 15%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected near vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Near vision after distance vision corrected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spectacle independent rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Defecation within 6 days after admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of intestinal pseudoobstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen saturation (SaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baroreflex sensitivity (BRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Willingness to donate kidney
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative laparoscopy rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of depressive symptoms in HRSD‐17 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of problem gambling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance on remote associates tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: practice effort on unicursal tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance walked during a 6-min walk test (6-MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hunger suppression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fullness enhancement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in children's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: QLROH
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average visual analog scale reading
Endpoint domain: Adverse events/effects
Primary endpoint: Average retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average time required per sitting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24-hour intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQ and EQ-5D scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Further surgery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative hip-related costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effective rate of wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of basophils expressing CD63
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPT induration diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to onset of unequivocal relief from an attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attacks per 12-week period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-hour CCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major postoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax after treatment with cisapride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: major postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of ultrasound-guided above the knee saphenous nerve blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of endolymphatic space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure Control Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction with the consent process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of the research purpose
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Appreciation of the voluntariness of participation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Nausea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of sun safety
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Comprehension of sun safety
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants evaluated as moderate or excellent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of neurological deficits
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter retention
Endpoint domain: Adverse events/effects
Primary endpoint: Progression to sight-threatening DME
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Airway resistance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of wheezing after intubation
Endpoint domain: Adverse events/effects
Primary endpoint: HECSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPOX gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glutathione reductase (GRd) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superoxide dismutase (SOD) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary-related behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate (bpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen consumption (O2 ml/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled carbon dioxide (CO2 ml/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reduction in androstenedione levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reduction in dehydroepiandrosterone sulphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reduction in free testosterone index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: incidence of MBEs during and up to 2 months after the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: TGF‐β expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient ratings of adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician ratings of adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain improvement score difference from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral rotation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb spasticity improvement for finger flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchial mast cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NGF expression in the bronchus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NGF mRNA levels in bronchial biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Breathing Frequency (BF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tidal Volume (VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Colorectal cancer (CRC) risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete STR before PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean corneal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to antipsychotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall WOMAC score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NHP distress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posaconazole exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total body oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shivering incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Non-cardiac side effects
Endpoint domain: Adverse events/effects
Primary endpoint: signs and symptoms of DED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rejection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Graft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ability to discontinue immunosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent searching for information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fixation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between MRI and pathology assessment of T stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Agreement between MRI and histological assessment of nodal status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Identification of circumferential resection margin involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: One-year patient survival rates
Endpoint domain: Mortality/survival
Primary endpoint: One-year graft survival rates
Endpoint domain: Mortality/survival
Primary endpoint: knee function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for LAD over TAD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desmopressin response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from DSM-IV disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal SCL90 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal SF36 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: secondary memory performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: speed of attention performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Missing data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per completed survey
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Readiness for Interprofessional Learning scale mean scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: withdrawal syndrome severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonization with clostridia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMP score gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: duration of total parenteral nutrition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: local control rate
Endpoint domain: Mortality/survival
Primary endpoint: Anxiety (assessed by VAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RSV-A neutralizing antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of NLFs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delta SDS (standardized height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who developed infections before discharge
Endpoint domain: Adverse events/effects
Primary endpoint: retrieved oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: info satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain medications used daily
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction of the Scale for the Assessment of Negative Symptoms (SANS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Amplitude of MEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Days of sick leave
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Ability to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Back pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean 6MWT distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physical HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean OHIP sum score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective improvement reported by athletes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Procedural pain of rTMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year patient survival
Endpoint domain: Mortality/survival
Primary endpoint: 2-year graft survival
Endpoint domain: Mortality/survival
Primary endpoint: Mean fever subsidence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean asexual form clearance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recrudescence rate
Endpoint domain: Adverse events/effects
Primary endpoint: marked improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: withdrawal due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: CR enrollment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Conversion to general anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Assessment of risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescribing of antiplatelet drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EQ-5D index scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EQ-5D visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median time to return to normal activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median CEAP class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to complete treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: recurrent anterior vaginal wall prolapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periprosthetic bone loss in zone 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: periprosthetic bone loss in zone 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: migration of stems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: LDL-C reduction from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the plasma concentration-time curve of oral oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean elimination half-life of oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported drug effect of oxycodone
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in LPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: catastrophic load to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pulmonary congestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peripheral oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of UTIs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of NEC
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of bacterial sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of instrumental vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Preference for testing method (IT vs NIPT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the time–concentration curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with the analgesic procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GU healing rates at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe acute nonhematologic toxicity
Endpoint domain: Adverse events/effects